Costanza Bosi

Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain

Simona Soverini, Sabrina Colarossi, Alessandra Gnani et al. · Haematologica · 2007 · 186 citations · Full text

Engineering, Mixed-phenotype Acute Leukemia, Pathology +18

Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis

Francesca Palandri, Massimo Breccia, Massimiliano Bonifacio et al. · Cancer · 2019 · 144 citations · Full text

Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS

Matilde Y. Follo, Carlo Finelli, Sara Mongiorgi et al. · Proceedings of the National Academy of Sciences · 2009 · 119 citations · Full text

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Acute Myeloid Leukemia +13

Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients

Maria Nyåkern, Pier Luigi Tazzari, Carlo Finelli et al. · Leukemia · 2005 · 101 citations

Hematological Malignancy, Bone Marrow Failure, Akt Kinase Phosphorylation +11

The Akt/Mammalian Target of Rapamycin Signal Transduction Pathway Is Activated in High-Risk Myelodysplastic Syndromes and Influences Cell Survival and Proliferation

Matilde Y. Follo, Sara Mongiorgi, Costanza Bosi et al. · Cancer Research · 2007 · 90 citations · Full text